South African Thoracic Society

EducAir launches 30 November 2022!

The South African Thoracic Society in collaboration with GSK South Africa is proud to present the EducAir online educational series available on this SATS website from 30 November 2022. This is part of SATS and GSK South Africa’s ongoing efforts to improve the management of patients living with obstructive airways disease in South Africa.

The first installment in the series consists of four modules focusing on clinical decision making with COPD patients and COPD pharmacological treatment options. This includes the latest recommendations from the Global Obstructive Lung Disease report (GOLD 2023). The modules are available on demand, each of the modules is CPD accredited meaning you can complete one module and receive CPD points, all you need to do is register. 

Each module has playback and repeat functions, a closed captions option, and extended narration to enhance your learning experience. On completion, you will also be able to share feedback on the module and we are looking forward to hearing from you on this.

The content includes materials useful for all levels of clinical practice for registered doctors and shares valuable learnings in the management of COPD patients. Certain medications and medical devices referred to in these training modules are not registered in South Africa, but are registered with the FDA and/or EMA with COPD patient management indications. These are included for educational purposes relevant to current guidelines on COPD treatment. The inclusion of medications and medication delivery devices does not imply the future registration of it in South Africa.

It is known in South Africa that patients living with COPD are underdiagnosed and undertreated and we hope that EducAir will contribute to improving on this for patients[1]. So, please do bookmark this page to engage with the content, share feedback and continue improving the lives of our patients.

[1] Brian Allwood and Richard N. van Zyl-Smit, “Chronic Obstructive Pulmonary Disease in South Africa: Under-Recognized and Undertreated,” South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde 105, no. 9 (September 2015): 785,

Dr Santoshni Govindasamy
GSK South Africa
Country Medical Director

Prof Richard van Zyl-Smit
South African Thoracic Society

Released 7 November 2022